Top analysts on stock perps · Analyst
Geulah Livshits (Chardan Capital): analyst track record on stock perps
Geulah Livshits of Chardan Capital on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.3★
Success37%
Excess return+9.6%
rank#1,627
Ratings491
ratings on stock perps14
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 61 | 181 |
| Stock | 23 | 26 |
| Buy / hold / sell | 60 / 1 / 0 | 179 / 2 / 0 |
| Upgrades / downgrades / initiations | 0 / 0 / 1 | 0 / 1 / 7 |
| Price targets hit / missed | 3 / 57 (5%) | 12 / 166 (7%) |
| Avg. return after a rating (TipRanks) | -56.0% | -59.9% |
| Best / worst call | +43.9% / -98.3% | +140.6% / -98.3% |
After buy calls: not enough measured cases yet
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $IOVA Iovance Biotherapeutics, Inc. | Buy · Reiterated | $14.00 | -0.6% | May 7, 2026 |
Recent ratings
- May 7, 2026 $IOVA: Reiterated · Buy · $14.00 · article
- Apr 10, 2026 $IOVA: Maintained · Buy · $16.00 · article
- Feb 24, 2026 $IOVA: Maintained · Buy · $16.00 · article
- Nov 6, 2025 $IOVA: Maintained · Buy · $17.00 · article
- Oct 7, 2025 $MRNA: Reiterated · Hold · article
- Aug 8, 2025 $IOVA: Maintained · Buy · $20.00 · article
- May 9, 2025 $IOVA: Maintained · Buy · $25.00 · article
- Mar 3, 2025 $IOVA: Maintained · Buy · $30.00 · article
- Feb 19, 2024 $IOVA: Reiterated · Buy · $34.00 · article
- Dec 27, 2023 $IOVA: Reiterated · Buy · $29.00 · article
- Nov 8, 2023 $IOVA: Reiterated · Buy · $29.00 · article
- Aug 16, 2023 $IOVA: Reiterated · Buy · $29.00 · article
- Aug 9, 2023 $IOVA: Reiterated · Buy · $29.00 · article
- Jul 10, 2023 $IOVA: Maintained · Buy · $29.00 · article
Geulah Livshits4.3★ · 37% success · +9.6% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.